Skip to content

Cannabis: all studies

Page 281 of 288: studies 2,801 to 2,810 of 2,878, newest first. Back to the cannabis overview

Research

The health effects of ecstasy: a literature review.

Drug and Alcohol Review March 2002 Linda R Gowing, Susan M Henry-Edwards, Rodney J. Irvine et al.

Ecstasy (3,4-methylenedioxymethamphetamine, MDMA) is the third most used illicit drug, after cannabis and amphetamines. There has been considerable interest in the adverse effects of use, with particular attention given to a small number of deaths related to ecstasy use, and the neurotoxic effects of MDMA. This paper reviews case reports of adverse effects attributed to ecstasy use, and the...

What Geometric Visual Hallucinations Tell Us about the Visual Cortex

Neural Computation March 1, 2002 Paul C. Bressloff, Jack D. Cowan, Martin Golubitsky et al. 292 citations

Many observers see geometric visual hallucinations after taking hallucinogens such as LSD, cannabis, mescaline or psilocybin; on viewing bright flickering lights; on waking up or falling asleep; in “near-death” experiences; and in many other syndromes. Klüver organized the images into four groups called form constants: (I) tunnels and funnels, (II) spirals, (III) lattices, including honeycombs...

DOI: 10.1162/089976602317250861 (opens in new tab) Psilocybin Visual cortex Euclidean geometry Homogeneous space +1

Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase.

Proceedings of the National Academy of Sciences of the United States of America July 31, 2001 Benjamin F Cravatt, K Demarest, M P Patricelli et al.

The medicinal properties of marijuana have been recognized for centuries, but clinical and societal acceptance of this drug of abuse as a potential therapeutic agent remains fiercely debated. An attractive alternative to marijuana-based therapeutics would be to target the molecular pathways that mediate the effects of this drug. To date, these neural signaling pathways have been shown to...

Cannabinoid-induced alterations in brain disposition of drugs of abuse.

Biochemical Pharmacology June 1, 2001 M J Reid, L M Bornheim

Marijuana contains a complex mixture of compounds including tetrahydrocannabinol (THC), the major psychoactive constituent, and cannabidiol (CBD), a nonpsychoactive constituent. We have shown previously that CBD pretreatment of mice increases brain levels of THC and have now further characterized this effect and determined whether the brain pharmacokinetics of other drugs are also affected. CBD...

Cannabinoids inhibit the formation of new synapses between hippocampal neurons in culture.

Journal of Neuroscience May 15, 2001 D Kim, S A Thayer

The principal psychoactive ingredient in marijuana, Delta(9)-tetrahydrocannabinol, has been shown to inhibit adenylyl cyclase activity in vitro and can lead to impairment of memory in vivo. cAMP-induced changes in synaptic plasticity are thought to underlie memory formation. We examined the effects of cannabinoid receptor agonists on forskolin-induced formation of new synapses between rat...

Recreational use of 3,4-methylenedioxymethamphetamine (MDMA) or ‘ecstasy’: evidence for cognitive impairment

Psychological Medicine May 1, 2001 Sarajane Bhattachary, Jane H. Powell 138 citations

Background. It has recently been shown that 3,4-methylenedioxymethamphetamine (MDMA) or ‘ecstasy’ causes long-lasting alterations to brain structure and function in animals, and there is mounting evidence that recreational users of the drug show impairments in some aspects of cognitive functioning including memory for verbal information. The present study investigates possible effects on other...

DOI: 10.1017/s0033291701003828 (opens in new tab) Ecstasy MDMA Memory span Verbal fluency test +10

Characteristics of pregnant women who use ecstasy (3, 4-methylenedioxymethamphetamine).

Neurotoxicology and Teratology 2001 E Ho, L Karimi-Tabesh, G Koren

To determine the characteristics of pregnant women who use Ecstasy (3,4-methylenedioxymethamphetamine, MDMA), and to identify reproductive risk factors associated with this group of women. Prospective, observational study. Pregnant women who have contacted the Motherisk Alcohol and Substance Use Helpline at The Hospital for Sick Children, in Toronto, about exposure to drugs, chemicals,...

The nonmedical use of ketamine, part two: A review of problem use and dependence.

Journal of Psychoactive Drugs 2001 K L Jansen, R Darracot-Cankovic

This is the second part of a review of the nonmedical use of ketamine. Part one discussed the history of ketamine, the sought-after effects for which it is taken in a nonmedical context, how these are produced, common adverse effects, the ketamine schizophrenia model and the neurotoxicity issue. Part two reviews what is currently known about problem use of ketamine, ketamine dependence,...

Primeiro perfil do usuário de "êxtase" (MDMA) em São Paulo

September 26, 2000 Stella Pereira De Almeida 1 citation

O presente estudo teve como objetivo identificar os padrões de uso de "êxtase"na cidade de São Paulo.Os usuários foram recrutados através da técnica de amostragem snowball, também utilizada para o recrutamento do grupo controle, composto de indivíduos com estilo de vida semelhante aos primeiros mas que nunca haviam experimentado "êxtase"(não usuários).Usuários (52) e não usuários (52) foram...

Salvia divinorum: an hallucinogenic mint which might become a new recreational drug in Switzerland.

Forensic Science International August 14, 2000 Christian Giroud, F Felber, Marc Augsburger et al. 70 citations

Salvia divinorum Epling & Jativa is an hallucinogenic mint traditionally used for curing and divination by the Mazatec Indians of Oaxaca, Mexico. Young people from Mexican cities were reported to smoke dried leaves of S. divinorum as a marijuana substitute. Recently, two S. divinorum specimens were seized in a large-scale illicit in-door and out-door hemp plantation. Salvinorin A also called...

DOI: 10.1016/s0379-0738(00)00180-8 (opens in new tab) Full text (opens in new tab) Salvia divinorum Salvinorin a: hallucinogen Psychoactive substance Entheogen +13